Concept explainers
Videos
CASE STUDY |A mysterious muscular dystrophy
A man in his early 30s suddenly developed weakness in his hands and neck, followed a few weeks later by burning muscle pain–all symptoms of late-onset muscular dystrophy. His internist ordered genetic tests to determine whether he had one of the inherited muscular dystrophies, focusing on Becker muscular dystrophy, myotonic dystrophy Type I, and myotonic dystrophy Type II. These tests were designed to detect mutations in the related dystrophin, DMPK, and ZNF9 genes. The testing ruled out Becker muscular dystrophy. While awaiting the results of the DMPK and ZNF9 gene tests, the internist explained that the possible mutations were due to expanded tri- and tetranucleotide repeats, but not in the protein-coding portion of the genes. She went on to say that the resulting disorders were due not to changes in the encoded proteins, which appear to be normal, but instead to altered RNA splicing patterns, whereby the RNA splicing remnants containing the
What is alternative splicing, where does it occur, and how could disrupting it affect the expression of the affected gene(s)?
Case summary:
A man experiences all the symptoms of late-onset muscular dystrophy including weakness in neck and hands and burning muscle pain. He has been prescribed several tests to detect mutations out of them Becker muscular dystrophy ruled out, results waited for DMPK and ZNF9 gene tests, so possible mutations were due to tri- and tetranucleotide repeats rather by changes to altered ribonucleotide acid (RNA) splicing patterns.
He has undergone different genetic tests to detect mutations in ZNF9, dystrophin, and DMPK.
Internist said that the disorder is due to changes in RNA splicing patterns and not in the protein-coding portions of the genes as the proteins appear to be normal.
Characters in the case:
A man with the symptoms of muscular dystrophy.
Adequate information:
Gene tests are the test to diagnose changes in chromosomal genes or proteins. These are mainly for abnormal chromosome number and mutations, which lead to inherited or rare disorder.
To determine:
Definition of alternative splicing and its occurrence, and the effects on expression of affected genes if it is disrupted.
Explanation of Solution
Given information:
A man with symptoms like muscular pain and weakness in hands and neck. Genetic test reveals Becker muscular dystrophy in this case, which is associated with the alteration in RNA splicing.
Alternate splicing also called as deferential splicing is the process occurs during gene expression resulting in different forms of mRNA from the identical pre-mRNA molecules, so we can say expression of a single gene leads to the formation of multiple proteins. In this process, the particular exons of a gene may be included or excluded from the final product of processed RNA. Resulting in changes in amino acids sequences and in there functioning. It occurs in spliceosome after the pre-mRNA has been transcribed.
Disruption in RNA processing can lead to miss-splicing of multiple transcripts, while alterations at single nucleotide lead to differences in single genes and thus in final product mRNA from a mutated gene. In case of muscular dystrophy, there is no change is recorded in protein products while the main cause is the accumulation of RNA in the nucleus, which have the toxic effects on the cells.
Hence, it can be concluded that Alternate splicing is a regulatory mechanism in eukaryotes, which removes or adds exons in the pre-mRNA polypeptide. However, alterations in these mechanisms lead to many inherited disorders because it will change the amino acid sequence and genes functioning.
Want to see more full solutions like this?
Chapter 15 Solutions
ESSENTIALS OF GENETICS MCC BUNDLE >BI<
- 6a. Given the following mutated sequence (with respect to the normal sequence), what TYPE of mutation occurred: AAGCTTACarrow_forwardFriedreich ataxia (FRDA) is an autosomal recessive, neurodegenerative disease that causes a lack of voluntary coordination of muscle movements. Affected individuals are homozygous for an unusually large number (expansion) of repeats of a trinucleotide sequence (GAA) in the first intron of the X25 gene. Unaffected individuals typically have between 7 and 38 repeats of the trinucleotide (GAAGAAGAAGAA…). FRDA patients have anywhere from 66 to over 1,700 repeats. To understand how the GAA trinucleotide expansion leads to FRDA, researchers looked at X25 gene expression by extracting RNA from affected and unaffected patients and doing a northern blot analysis (see the figure below): In panel “a,” the researchers used a probe to detect X25 mRNA. In panel “b,” the researchers used a probe on a duplicate of the original blot to detect human GAPDH mRNA (GAPDH is an enzyme involved in glycolysis). The sample labeled “YR” is mRNA from yeast cells that was used as a control. Explain…arrow_forwardQuestion:- Often a given mutation or variant will have slightly different phenotypes in different groups of patients. “Genetic Background” is frequently used to explain how the same exact mutation could exhibit different phenotypes in different populations. Please explain.arrow_forward
- 6a. Given the following mutated sequence (with respect to the normal sequence), what TYPE of mutation occurred: AAGCTTAC 6b. Where did the mutation take place?arrow_forwardCh. 18-2 The photos shown below illustrate a case of synpolydactyly, a genetic abnormality characterized by two phenotypes: partially or completely duplicated fingers or toes, and webbing between fingers or toes. The same mutations that give rise to the human phenotype also give rise to a similar phenotype in mice. In which family of genes do you think these mutations occur?arrow_forward8a. Given the following mutated sequence (with respect to the normal sequence), what TYPE of mutation occurred: AAACGTTAC 8b. Where did the mutation take place?arrow_forward
- 33. For the following gene, which type of regulatory sequence has likely been deleted in mutant 1?arrow_forwardTwo related forms of muscular dystrophy—Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD)—are both recessive, X-linked, single-gene conditions caused by point mutations, deletions, and insertion in the dystrophin gene. Each mutated form of dystrophin is one allele. Of the two diseases, DMD is much more severe. Given your knowledge of mutations, the genetic code, and translation, propose an explanation for why the two disorders differ greatly in severity.arrow_forward1. a)What would happen if the aminoacyl tRNA synthetase responsible for charging alanine tRNAs also charged methionine tRNAs with alanine? b)What would happen if an individual was homozygous for mutant alleles of the gene encoding the aminoacyl tRNA synthetase responsible for charging leucine tRNAs?arrow_forward
- Huntington disease (HD) can arise from a rare, short, in-frame addition of CAG nucleotide triplets within the huntingtin (HTT) gene coding region, which creates a disease-causing allele with the symptoms only appearing later in life. Using this information, describe an experiment that could be undertaken to determine whether a currently healthy young individual is a carrier of the HD-causing mutation. Describe the method you would use and how you would interpret the results of this experiment.arrow_forward1). In the absence of this enzyme, a substance called ceroid lipofuscin accumulates in lysosomes in the brain, resulting in seizures, blindness, decline in cognitive function and motor skills, dementia, and death by the late teens or early 20’s. The TPP1 gene is 6695 bp in length. Think about the characteristics of Batten disease, and then suggest an approach to gene therapy that might be effective for this specific genetic disorder. You may assume that your research team is working in the U.S. and your research is funded by a grant from the National Institutes of Health (NIH). a) Hypothetically, what specific type of VECTOR will you use to perform your gene therapy? Please select from the following list of potential vectors: disabled retrovirus, adenovirus, adeno-associated virus (AAV), or herpes simplex virus (HSV), then give two reasons why this specific vector is the most appropriate for your gene therapy. Please explain why you were able to rule out the other potential…arrow_forward1). In the absence of this enzyme, a substance called ceroid lipofuscin accumulates in lysosomes in the brain, resulting in seizures, blindness, decline in cognitive function and motor skills, dementia, and death by the late teens or early 20’s. The TPP1 gene is 6695 bp in length. Think about the characteristics of Batten disease, and then suggest an approach to gene therapy that might be effective for this specific genetic disorder. You may assume that your research team is working in the U.S. and your research is funded by a grant from the National Institutes of Health (NIH). Other scientists have suggested that it might be possible to use CRISPR to treat this genetic disorder in affected individuals. (i) First, what is CRISPR? (BRIEFLY describe what it is and how it works). (ii) Briefly describe how CRISPR could be utilized in treating genetic conditions such as Batten disease.arrow_forward
Biology: The Dynamic Science (MindTap Course List)BiologyISBN:9781305389892Author:Peter J. Russell, Paul E. Hertz, Beverly McMillanPublisher:Cengage Learning
Biology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStax